Estée Lauder in Talks to Buy Puig to Create Beauty Giant | Bloomberg Intelligence
March 24, 2026
381
5
1
1.57%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Podcasts Episodes Around March 24, 2026
See what was published immediately before and after this episode.
21:50Now PlayingEstée Lauder in Talks to Buy Puig to Create Beauty Giant | Bloomberg Intelligence
YouTube Description
as posted by the channelWatch Scarlet and Paul LIVE every day on YouTube().
Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu
-Clara Hernanz Lizarraga, Bloomberg Companies Reporter, discusses Estée Lauder being in talks to buy Puig Brands, which would create a cosmetics giant with about $20 billion in annual sales. A takeover of Puig would give Estée Lauder well-known perfume and fashion brands such as Rabanne, Jean Paul Gaultier and Carolina Herrera.
-Steve Man, Bloomberg Intelligence Global Autos and Industrials Research Analyst, discusses why a prolonged war with recession threatens a 15% drop in auto sales. According to Bloomberg Intelligence: a sustained spike in Brent crude oil above $100 a barrel favors automakers like Toyota, Tesla and Rivian due to their many hybrids and affordable battery electric vehicles.
-Jennifer Rie, Bloomberg Intelligence Senior Litigation Analyst, discusses Bloomberg Intelligence research on why Nexstar’s Tegna acquisition appears to be at risk of legal pause. Nexstar closed its purchase of Tegna on March 19 after being cleared by the FCC and Justice Department, yet the deal isn't free from risk due to lawsuits to unwind it by eight states and DirecTV.
-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in the biotech sector. Pfizer said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, a lackluster result as fewer-than-expected infections in the pivotal study made its potency hard to evaluate.
See omnystudio.com/listener () for privacy information.
Paul Sweeney and the Bloomberg News team cover the day's market action, with analysis from Bloomberg Intelligence analysts, Bloomberg Opinion writers and influential newsmakers.
Watch us LIVE on YouTube
Subscribe to Bloomberg Podcasts
Listen to more Bloomberg Intelligence
#News #Markets #Bloomberg #Podcast #Business #Finance
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.